Forward Pharma (FWP) Says It's Disappointed with European Patent Office Decision to Revoke '355 Patent
Tweet Send to a Friend
Forward Pharma A/S (NASDAQ: FWP) (“Forward” or the “Company”) today announced that the European Patent Office (the “EPO”) has revoked ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
